Gaba Newro Capsule 25 mg (Pregabalin)

Adult dose

This drug is administered orally, dividing the total daily dose into two doses, regardless of food intake. Neuropathic Pain (Peripheral and Central): The starting dose is 150 mg daily, and depending on the patient's response and tolerability, it can be increased to 300 mg per day within 3 days to 1 week. If necessary, it can be gradually increased to a maximum of 600 mg per day at 7-day intervals. Epilepsy: The starting dose is 150 mg daily, and after a week

Child dose

The safety and efficacy data for children under the age of 12 and adolescents aged 12 to 17 is insufficient, so administration is not recommended.

This drug may increase the risk of suicidal thoughts or behaviors, so any changes in mood or behavior during treatment should be reported immediately to a healthcare provider. Individuals allergic to pregabalin or any component of this drug should not take it, and it should also be avoided in cases of certain genetic disorders like lactose intolerance. Diabetic patients should be cautious as weight gain may necessitate adjustments in blood sugar control medications. If any signs of angioedema appear, the drug should be stopped immediately, and elderly patients should be careful due to the risk of falls from dizziness and drowsiness. Visual disturbances such as blurred vision may occur, and these symptoms may improve after discontinuation of the medication. If pregabalin is suddenly stopped, withdrawal symptoms like insomnia, headaches, and anxiety may appear, so it should be tapered gradually in consultation with a healthcare provider. Patients with a history of drug abuse have a higher risk of misuse or dependence on this drug, and caution should be exercised during use. Patients with impaired kidney function may require dose adjustments. Patients with heart disease should be cautious when taking this drug, and co-administration with opioid analgesics may increase the risk of central nervous system depression. In early pregnancy, there is a risk of fetal malformation, so women who are pregnant or planning to become pregnant should ensure they consult their healthcare provider before taking this medication and should use effective contraception. Breastfeeding women should discuss with their healthcare provider whether to discontinue breastfeeding or the medication as this drug may pass into breast milk. Dizziness and drowsiness may occur during treatment, so driving or operating hazardous machinery should be avoided until symptoms are resolved. In the event of an overdose, symptoms such as confusion, drowsiness, or depression may appear, so contact a medical professional immediately for appropriate treatment. Keep out of reach of children and ensure it is not transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headaches, seizures, confusion of consciousness, visual abnormalities, paralysis, urination issues

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medicine should be stored in a tightly sealed container to prevent moisture or air exposure, preferably in a cool place between 15 and 30 degrees Celsius. Proper storage will help to maintain the drug's effectiveness.

Appearance

A capsule with a pale yellow upper part and a white lower part containing a white or light yellow powder.

Package unit

30 capsules/bottle, 100 capsules/bottle